scholarly journals ARE THERE DIFFERENCES IN ORAL ANTICOAGULANT THERAPIES IN HOSPITALIZED PATIENTS WITH ATRIAL FIBRILLATION AND MODERATE VERSUS SEVERE RENAL DYSFUNCTION?

2018 ◽  
Vol 34 (10) ◽  
pp. S183-S184
Author(s):  
Z. Mariano ◽  
G. Thomas ◽  
P. Dorian ◽  
J. Cruz ◽  
K. Ahmad ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Renal Dysfunction ◽  
Oral Anticoagulant ◽  
Hospitalized Patients ◽  
Severe Renal Dysfunction

scholarly journals Renal function and oral anticoagulant treatment of incident non-valvular atrial fibrillation: a retrospective study

2019 ◽  
Vol 15 (4) ◽  
pp. 301-309 ◽  
Author(s):  
Sreeram V Ramagopalan ◽  
Elaine Stamp ◽  
Cormac J Sammon ◽  
Megan Besford ◽  
Robert Carroll ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Renal Function ◽  
Renal Dysfunction ◽  
Oral Anticoagulant ◽  
Treatment Initiation ◽  
Newly Diagnosed ◽  
Oral Anticoagulant Treatment ◽  
Treatment Prevalence ◽  
High Prevalence ◽  
Severe Renal Dysfunction

Aim: To describe the renal function of individuals newly diagnosed with non-valvular atrial fibrillation in England, and describe how oral anticoagulant (OAC) treatment varies according to renal function. Patients & methods: We identified a cohort of individuals with non-valvular atrial fibrillation (n = 18,419) and described their renal function at diagnosis and the prevalence of OAC treatment initiation by renal function. Results: 79% of individuals had some evidence of renal dysfunction with 12% having a glomerular filtration rate <30 ml/min/1.73 m2. OAC treatment initiation in the 6 months following diagnosis was lower in individuals with severe renal dysfunction than in those with normal renal function. Conclusion: The high prevalence of renal dysfunction and low OAC treatment prevalence highlights the need for additional evidence regarding OACs in individuals with severe renal dysfunction.

scholarly journals Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction

2017 ◽  
Vol 69 (23) ◽  
pp. 2779-2790 ◽  
Author(s):  
Xiaoxi Yao ◽  
Nilay D. Shah ◽  
Lindsey R. Sangaralingham ◽  
Bernard J. Gersh ◽  
Peter A. Noseworthy
Keyword(s):  
Atrial Fibrillation ◽  
Renal Dysfunction ◽  
Vitamin K ◽  
Oral Anticoagulant ◽  
Vitamin K Antagonist

scholarly journals RATES OF ORAL ANTICOAGULANT USE, WHILE IMPROVING OVER TIME, REMAIN LOW AMONG HOSPITALIZED PATIENTS WITH ATRIAL FIBRILLATION

2017 ◽  
Vol 69 (11) ◽  
pp. 363 ◽  
Author(s):  
Sean Pokorney ◽  
Christopher Granger ◽  
Kevin Anstrom ◽  
Eva Kline-Rogers ◽  
Mark Alberts ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Oral Anticoagulant ◽  
Hospitalized Patients ◽  
Over Time

Factors associated with discontinuing or not starting oral anticoagulant therapy in older hospitalized patients with non-valvular atrial fibrillation

2018 ◽  
Vol 18 (8) ◽  
pp. 1219-1224 ◽  
Author(s):  
Jesús Díez-Manglano ◽  
José-María Mostaza ◽  
Antonio Pose ◽  
Francesc Formiga ◽  
José-María Cepeda ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Anticoagulant Therapy ◽  
Oral Anticoagulant ◽  
Oral Anticoagulant Therapy ◽  
Hospitalized Patients ◽  
Factors Associated
Sign in / Sign up

Export Citation Format

Share Document